Biolase (BIOL) Misses Q2 EPS by 7c

Biolase (NASDAQ: BIOL) reported Q2 EPS of ($0.10), $0.07 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $13.8 million versus the consensus estimate of $12.9 million.

For earnings history and earnings-related data on Biolase (BIOL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery